VERA
Vera Therapeutics, Inc.
Company overview
- Market capitalization
- $2.34B
- Employees
- 339
- Latest publication
- 2026-09-29
About Vera Therapeutics, Inc.
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with immunological diseases. The company offers atacicept, a fully humanized TACI-Fc fusion protein that binds B-cell activating factor (BAFF) and A proliferation-inducing ligand (APRIL), which is self-administered at home as a subcutaneous injection being evaluated for the treatment of immunoglobulin A nephropathy (IgAN) and other autoimmune kidney diseases. It is also developing MAU868, a human monoclonal antibody for the treatment of BK viremia infections that has completed phase 2 clinical trial; and VT-109, a novel BAFF/APRIL dual-inhibitor B cell maturation antigen (BCMA) molecule to treat B cell mediated autoimmune diseases. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 256,000USD | -1,127,000USD | 564,000USD | 563,000USD | — | — | — | — |
| Gross Profit | -256,000USD | 1,127,000USD | -564,000USD | -563,000USD | — | — | — | — |
| Research Development | 86,011,000USD | 59,558,000USD | 56,473,000USD | 58,076,000USD | 41,278,000USD | 33,347,000USD | 40,314,000USD | 29,311,000USD |
| Selling General Administrative | 39,121,000USD | 34,896,000USD | 21,754,000USD | 21,946,000USD | 14,580,000USD | 15,567,000USD | 9,487,000USD | 8,032,000USD |
| Total Operating Expenses | 125,132,000USD | 95,333,000USD | 83,932,000USD | 79,578,000USD | 57,194,000USD | 48,914,000USD | 49,801,000USD | 37,343,000USD |
| Operating Income | -125,132,000USD | -94,206,000USD | -83,932,000USD | -80,141,000USD | -57,194,000USD | -48,914,000USD | -49,801,000USD | -37,343,000USD |
| Interest Income | 6,355,000USD | 5,517,000USD | 5,736,000USD | 6,320,000USD | 6,906,000USD | 6,663,000USD | 4,761,000USD | 5,104,000USD |
| Interest Expense | 1,823,000USD | 5,626,000USD | 1,960,000USD | 1,874,000USD | 1,792,000USD | 1,871,000USD | 1,936,000USD | 1,912,000USD |
| Net Interest Income | 4,532,000USD | 3,613,000USD | 3,776,000USD | 4,446,000USD | 5,114,000USD | 4,792,000USD | 2,825,000USD | 3,192,000USD |
| Income Before Tax | -121,032,000USD | -91,098,000USD | -80,293,000USD | -76,531,000USD | -51,694,000USD | -43,424,000USD | -46,632,000USD | -33,708,000USD |
| Net Income | -121,032,000USD | -91,097,000USD | -80,293,000USD | -76,531,000USD | -51,694,000USD | -43,425,000USD | -46,632,000USD | -33,708,000USD |
| Net Income From Continuing Ops | -121,032,000USD | -91,097,000USD | -80,293,000USD | -76,531,000USD | -51,694,000USD | -43,425,000USD | -46,632,000USD | -33,708,000USD |
| Ebit | -119,209,000USD | -85,472,000USD | -78,333,000USD | -74,657,000USD | -49,902,000USD | -41,553,000USD | -44,696,000USD | -31,796,000USD |
| Ebitda | -118,953,000USD | -85,337,000USD | -78,204,000USD | -74,094,000USD | -49,817,000USD | -41,498,000USD | -44,672,000USD | -30,301,000USD |
| Depreciation And Amortization | 256,000USD | 135,000USD | 129,000USD | 563,000USD | 85,000USD | 55,000USD | 24,000USD | 1,495,000USD |
| Reconciled Depreciation | 140,000USD | 135,000USD | 129,000USD | 119,000USD | 85,000USD | 55,000USD | 24,000USD | 1,495,000USD |
| Total Other Income Expense Net | 4,100,000USD | 3,108,000USD | 3,639,000USD | 3,610,000USD | 5,500,000USD | 5,490,000USD | 3,169,000USD | 3,635,000USD |
| Income Tax Expense | — | -1,000USD | — | — | — | 1,000USD | — | — |
| Selling And Marketing Expenses | — | — | 5,705,000USD | — | 1,336,000USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 1,862,000USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 468,000USD | 2,169,000USD | -1,862,000USD | -846,000USD | 176,000USD | 251,000USD | 509,000USD |
| Gross Profit | -468,000USD | -2,169,000USD | 1,862,000USD | 846,000USD | -176,000USD | -251,000USD | -509,000USD |
| Research Development | 215,256,000USD | 126,172,000USD | 78,225,000USD | 68,993,000USD | 22,484,000USD | 43,916,000USD | 7,290,000USD |
| Selling General Administrative | 100,217,000USD | 40,998,000USD | 23,787,000USD | 21,910,000USD | 11,918,000USD | 4,039,000USD | 4,410,000USD |
| Total Operating Expenses | 315,473,000USD | 167,170,000USD | 102,012,000USD | 90,903,000USD | 34,402,000USD | 47,809,000USD | 11,700,000USD |
| Operating Income | -315,473,000USD | -167,170,000USD | -102,012,000USD | -90,903,000USD | -34,402,000USD | -48,060,000USD | -11,961,000USD |
| Interest Income | 24,479,000USD | 20,714,000USD | 6,913,000USD | 1,750,000USD | 15,000USD | 8,000USD | 159,000USD |
| Interest Expense | 7,531,000USD | 7,626,000USD | 3,786,000USD | 992,000USD | 20,000USD | 166,000USD | 51,000USD |
| Net Interest Income | 16,948,000USD | 13,088,000USD | 3,584,000USD | 758,000USD | -5,000USD | -95,000USD | 108,000USD |
| Income Before Tax | -299,614,000USD | -152,147,000USD | -95,989,000USD | -89,055,000USD | -32,608,000USD | -53,412,000USD | -11,853,000USD |
| Income Tax Expense | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD |
| Tax Provision | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD |
| Net Income | -299,615,000USD | -152,148,000USD | -95,990,000USD | -89,056,000USD | -32,609,000USD | -53,413,000USD | -11,854,000USD |
| Net Income From Continuing Ops | -299,615,000USD | -152,148,000USD | -102,774,000USD | 89,056,000USD | -32,609,000USD | -53,413,000USD | -11,854,000USD |
| Ebit | -292,083,000USD | -144,521,000USD | -92,203,000USD | -90,903,000USD | -34,402,000USD | -53,246,000USD | -11,802,000USD |
| Ebitda | -291,615,000USD | -144,416,000USD | -92,182,000USD | -91,749,000USD | -34,226,000USD | -52,995,000USD | -11,293,000USD |
| Depreciation And Amortization | 468,000USD | 105,000USD | 21,000USD | -846,000USD | 176,000USD | 251,000USD | 509,000USD |
| Reconciled Depreciation | 468,000USD | 105,000USD | -3,516,000USD | -846,000USD | 176,000USD | 251,000USD | 509,000USD |
| Total Other Income Expense Net | 15,859,000USD | 15,023,000USD | 6,023,000USD | 1,848,000USD | 1,794,000USD | -5,352,000USD | 108,000USD |
| Non Operating Income Net Other | — | — | — | -2,840,000USD | 1,814,000USD | — | — |
| Net Income Applicable To Common Shares | — | — | — | 89,056,000USD | -32,609,000USD | -53,413,000USD | -11,854,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 621,739,000USD | 734,733,000USD | 517,503,000USD | 578,528,000USD | 610,167,000USD | 655,681,000USD | 368,560,000USD | 397,291,000USD |
| Other Current Assets | 15,134,000USD | 11,009,000USD | 5,485,000USD | 10,325,000USD | 12,656,000USD | 6,593,000USD | 10,822,000USD | 8,400,000USD |
| Total Liab | 122,042,000USD | 130,212,000USD | 118,623,000USD | 110,251,000USD | 75,168,000USD | 78,526,000USD | 79,502,000USD | 69,422,000USD |
| Total Stockholder Equity | 499,697,000USD | 604,521,000USD | 398,880,000USD | 468,277,000USD | 534,999,000USD | 577,155,000USD | 289,058,000USD | 327,869,000USD |
| Other Current Liab | 31,240,000USD | 31,008,000USD | 23,457,000USD | 19,542,000USD | 11,441,000USD | 16,223,000USD | 19,990,000USD | 11,638,000USD |
| Common Stock | 72,000USD | 71,000USD | 64,000USD | 64,000USD | 64,000USD | 64,000USD | 55,000USD | 55,000USD |
| Capital Stock | 72,000USD | 71,000USD | 64,000USD | 64,000USD | 64,000USD | 64,000USD | 55,000USD | 55,000USD |
| Retained Earnings | -881,897,000USD | -760,865,000USD | -669,768,000USD | -589,475,000USD | -512,944,000USD | -461,250,000USD | -417,825,000USD | -371,193,000USD |
| Cash | 114,351,000USD | 354,725,000USD | 57,773,000USD | 49,121,000USD | 55,090,000USD | 92,646,000USD | 27,256,000USD | 25,085,000USD |
| Cash And Short Term Investments | 596,760,000USD | 714,589,000USD | 497,389,000USD | 556,827,000USD | 589,834,000USD | 640,852,000USD | 353,309,000USD | 384,387,000USD |
| Total Current Assets | 615,802,000USD | 728,883,000USD | 506,231,000USD | 571,354,000USD | 606,076,000USD | 651,218,000USD | 364,131,000USD | 394,747,000USD |
| Total Current Liabilities | 45,149,000USD | 53,455,000USD | 41,880,000USD | 33,554,000USD | 21,894,000USD | 25,371,000USD | 26,464,000USD | 18,418,000USD |
| Net Debt | -39,322,000USD | -277,419,000USD | 19,443,000USD | 28,431,000USD | -625,000USD | -38,008,000USD | 27,654,000USD | 27,749,000USD |
| Short Long Term Debt Total | 75,029,000USD | 77,306,000USD | 77,216,000USD | 77,552,000USD | 54,465,000USD | 54,638,000USD | 54,910,000USD | 52,834,000USD |
| Long Term Debt | 75,029,000USD | 74,838,000USD | 74,648,000USD | 74,464,000USD | 50,908,000USD | 50,687,000USD | 50,470,000USD | 50,263,000USD |
| Short Term Investments | 482,409,000USD | 359,864,000USD | 439,616,000USD | 507,706,000USD | 534,744,000USD | 548,206,000USD | 326,053,000USD | 359,302,000USD |
| Net Receivables | 3,908,000USD | 3,285,000USD | 3,357,000USD | 4,202,000USD | 3,586,000USD | 3,773,000USD | 1,997,000USD | 1,960,000USD |
| Accounts Payable | 13,909,000USD | 21,898,000USD | 17,950,000USD | 13,157,000USD | 9,262,000USD | 7,665,000USD | 4,602,000USD | 4,664,000USD |
| Property Plant Equipment Net | 2,751,000USD | 1,923,000USD | 3,191,000USD | 3,622,000USD | 3,977,000USD | 4,332,000USD | 4,289,000USD | 2,084,000USD |
| Accumulated Other Comprehensive Income | -156,000USD | 786,000USD | 881,000USD | 527,000USD | 654,000USD | 393,000USD | 1,044,000USD | -450,000USD |
| Common Stock Shares Outstanding | 71,476,595shares | 64,233,814shares | 63,847,055shares | 63,789,303shares | 63,671,558shares | 54,898,297shares | 54,898,297shares | 54,728,552shares |
| Non Current Assets Total | 5,937,000USD | 5,850,000USD | 11,272,000USD | 7,174,000USD | 4,091,000USD | 4,463,000USD | 4,429,000USD | 2,544,000USD |
| Non Current Liabilities Total | 76,893,000USD | 76,757,000USD | 76,743,000USD | 76,697,000USD | 53,274,000USD | 53,155,000USD | 53,038,000USD | 51,004,000USD |
| Non Currrent Assets Other | 3,186,000USD | 3,927,000USD | 8,081,000USD | 3,552,000USD | 114,000USD | 131,000USD | 140,000USD | 460,000USD |
| Net Working Capital | 570,653,000USD | 675,428,000USD | 469,431,000USD | 537,800,000USD | 584,182,000USD | 625,847,000USD | 337,667,000USD | 376,329,000USD |
| Unclassified Non Current Liabilities | 1,864,000USD | 1,919,000USD | 2,095,000USD | 2,233,000USD | 2,366,000USD | 2,468,000USD | 2,568,000USD | — |
| Unclassified Equity | 1,381,606,000USD | 1,364,458,000USD | 1,067,639,000USD | 1,057,097,000USD | 1,047,161,000USD | 1,037,884,000USD | 705,729,000USD | 699,402,000USD |
| Short Term Debt | — | 549,000USD | 473,000USD | 855,000USD | 1,191,000USD | 1,483,000USD | 1,872,000USD | 2,116,000USD |
| Property Plant Equipment Gross | — | 3,297,000USD | 3,191,000USD | 3,622,000USD | 3,977,000USD | 4,332,000USD | 4,289,000USD | 2,084,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Assets | 734,733,000USD | 655,681,000USD | 175,546,000USD | 131,435,000USD | 83,748,000USD | 54,554,000USD | 5,381,000USD |
| Other Current Assets | 11,009,000USD | 6,593,000USD | 11,307,000USD | 11,045,000USD | 2,863,000USD | 555,000USD | 370,000USD |
| Total Liab | 130,212,000USD | 78,526,000USD | 73,861,000USD | 54,527,000USD | 14,156,000USD | 143,902,000USD | 41,929,000USD |
| Total Stockholder Equity | 604,521,000USD | 577,155,000USD | 101,685,000USD | 76,908,000USD | 69,592,000USD | -89,348,000USD | -36,548,000USD |
| Other Current Liab | 31,008,000USD | 16,223,000USD | 8,749,000USD | 10,964,000USD | 6,305,000USD | 1,495,000USD | 596,000USD |
| Common Stock | 71,000USD | 64,000USD | 44,000USD | 28,000USD | 21,000USD | 4,000USD | 4,000USD |
| Capital Stock | 71,000USD | 64,000USD | 44,000USD | 28,000USD | 21,000USD | 0USD | 0USD |
| Retained Earnings | -760,865,000USD | -461,250,000USD | -309,102,000USD | -213,112,000USD | -124,056,000USD | -91,447,000USD | -38,034,000USD |
| Cash | 354,725,000USD | 92,646,000USD | 45,681,000USD | 43,459,000USD | 79,674,000USD | 53,654,000USD | 3,195,000USD |
| Cash And Short Term Investments | 714,589,000USD | 640,852,000USD | 160,716,000USD | 114,653,000USD | 79,674,000USD | 53,654,000USD | 3,195,000USD |
| Total Current Assets | 728,883,000USD | 651,218,000USD | 172,023,000USD | 125,698,000USD | 82,537,000USD | 54,261,000USD | 3,565,000USD |
| Total Current Liabilities | 53,455,000USD | 25,371,000USD | 22,303,000USD | 25,600,000USD | 7,690,000USD | 2,406,000USD | 1,060,000USD |
| Net Debt | -277,419,000USD | -38,008,000USD | 8,027,000USD | -12,173,000USD | -74,751,000USD | -53,652,000USD | -3,063,000USD |
| Short Term Debt | 549,000USD | 1,483,000USD | 2,436,000USD | 2,645,000USD | — | 2,000USD | 122,000USD |
| Short Long Term Debt Total | 77,306,000USD | 54,638,000USD | 53,708,000USD | 31,286,000USD | 4,923,000USD | 2,000USD | 132,000USD |
| Long Term Debt | 74,838,000USD | 50,687,000USD | 49,877,000USD | 24,810,000USD | 4,923,000USD | — | — |
| Short Term Investments | 359,864,000USD | 548,206,000USD | 115,035,000USD | 71,194,000USD | 867,000USD | 86USD | 34USD |
| Net Receivables | 3,285,000USD | 3,773,000USD | — | — | — | 52,000USD | — |
| Accounts Payable | 21,898,000USD | 7,665,000USD | 11,118,000USD | 11,991,000USD | 1,385,000USD | 909,000USD | 342,000USD |
| Property Plant Equipment Net | 1,923,000USD | 4,332,000USD | 3,041,000USD | 5,224,000USD | 0USD | 0USD | 1,394,000USD |
| Property Plant Equipment Gross | 3,297,000USD | 4,332,000USD | 3,041,000USD | 5,173,000USD | 0USD | 0USD | 1,394,000USD |
| Accumulated Other Comprehensive Income | 786,000USD | 393,000USD | 251,000USD | -224,000USD | 0USD | -139,580,000USD | -40,099,000USD |
| Common Stock Shares Outstanding | 64,233,814shares | 55,326,680shares | 42,707,072shares | 26,570,676shares | 13,435,706shares | 3,708,152shares | 3,422,676shares |
| Non Current Assets Total | 5,850,000USD | 4,463,000USD | 3,523,000USD | 5,737,000USD | 1,211,000USD | 293,000USD | 1,816,000USD |
| Non Current Liabilities Total | 76,757,000USD | 53,155,000USD | 51,558,000USD | 28,927,000USD | 6,466,000USD | 141,496,000USD | 40,869,000USD |
| Non Currrent Assets Other | 3,927,000USD | 131,000USD | 471,000USD | 455,000USD | 344,000USD | 293,000USD | 422,000USD |
| Net Working Capital | 675,428,000USD | 625,847,000USD | 149,720,000USD | 100,098,000USD | 74,847,000USD | 51,855,000USD | 2,505,000USD |
| Unclassified Non Current Liabilities | 1,919,000USD | 2,468,000USD | 1,681,000USD | — | -1,257,000USD | 137,942,000USD | 40,105,000USD |
| Unclassified Equity | 1,364,458,000USD | 1,037,884,000USD | 410,448,000USD | 290,188,000USD | 193,606,000USD | 141,675,000USD | 41,581,000USD |
| Other Assets | — | — | 1USD | 455,000USD | 344,000USD | 293,000USD | 422,000USD |
| Other Liab | — | — | — | 286,000USD | 1,543,000USD | 1,920,000USD | 764,000USD |
| Long Term Investments | — | — | — | 58,000USD | 867,000USD | 0USD | — |
| Non Current Liabilities Other | — | — | — | 4,117,000USD | 1,257,000USD | 1,634,000USD | — |
| Net Tangible Assets | — | — | — | 76,908,000USD | 69,592,000USD | -89,348,000USD | -36,548,000USD |
| Current Deferred Revenue | — | — | — | — | — | 533,000USD | 376,000USD |
| Inventory | — | — | — | — | — | 472,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -121,032,000USD | -91,097,000USD | -80,293,000USD | -76,531,000USD | -51,694,000USD | -43,425,000USD | -46,632,000USD | -33,708,000USD |
| Depreciation | 256,000USD | 135,000USD | 129,000USD | 119,000USD | 85,000USD | 55,000USD | 24,000USD | 15,000USD |
| Stock Based Compensation | 13,208,000USD | 10,965,000USD | 9,745,000USD | 9,472,000USD | 7,744,000USD | 6,217,000USD | 5,588,000USD | 4,873,000USD |
| Other Non Cash Items | 14,796,000USD | -359,000USD | -173,000USD | -1,240,000USD | -1,103,000USD | -1,301,000USD | -1,728,000USD | -2,106,000USD |
| Change In Working Capital | -13,728,000USD | 10,362,000USD | 8,686,000USD | 13,382,000USD | -9,438,000USD | -728,000USD | 5,863,000USD | 6,144,000USD |
| Total Cash From Operating Activities | -106,500,000USD | -69,994,000USD | -61,906,000USD | -54,798,000USD | -54,406,000USD | -39,182,000USD | -36,885,000USD | -24,782,000USD |
| Capital Expenditures | -173,000USD | -102,000USD | -133,000USD | -208,000USD | -187,000USD | -645,000USD | -25,109,000USD | -89,000USD |
| Free Cash Flow | -106,673,000USD | -70,096,000USD | -62,039,000USD | -55,006,000USD | -54,593,000USD | -39,827,000USD | -61,994,000USD | -24,871,000USD |
| Investments | -122,643,000USD | 80,766,000USD | 69,761,000USD | 28,544,000USD | 15,317,000USD | -221,383,000USD | 38,317,000USD | -22,677,000USD |
| Total Cashflows From Investing Activities | -137,816,000USD | 80,664,000USD | 69,761,000USD | 28,544,000USD | 15,317,000USD | -221,383,000USD | 38,317,000USD | -22,677,000USD |
| Total Cash From Financing Activities | 3,942,000USD | 286,282,000USD | 797,000USD | 20,285,000USD | 1,533,000USD | 325,955,000USD | 739,000USD | 3,439,000USD |
| Change In Cash | -240,374,000USD | 296,952,000USD | 8,652,000USD | -5,969,000USD | -37,556,000USD | 65,390,000USD | 2,171,000USD | -44,020,000USD |
| Begin Period Cash Flow | 354,725,000USD | 57,773,000USD | 49,121,000USD | 55,090,000USD | 92,646,000USD | 27,256,000USD | 25,085,000USD | 69,105,000USD |
| End Period Cash Flow | 114,351,000USD | 354,725,000USD | 57,773,000USD | 49,121,000USD | 55,090,000USD | 92,646,000USD | 27,256,000USD | 25,085,000USD |
| Other Cashflows From Investing Activities | -15,000,000USD | — | — | -50,000USD | -750,000USD | — | 24,871,000USD | -89,000USD |
| Net Borrowings | — | 0USD | 0USD | — | — | — | — | — |
| Sale Purchase Of Stock | — | 0USD | — | — | — | 0USD | -13,000USD | — |
| Issuance Of Capital Stock | — | 300,500,000USD | 0USD | 0USD | 0USD | 345,000,000USD | 0USD | 0USD |
| Other Cashflows From Financing Activities | — | -18,405,000USD | 797,000USD | 19,821,000USD | 1,533,000USD | -19,045,000USD | 752,000USD | 3,439,000USD |
| Unclassified Financing Cash Flow | — | 304,687,000USD | — | — | — | 345,000,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Net Income | -299,615,000USD | -152,148,000USD | -95,990,000USD | -89,056,000USD | -32,609,000USD | -53,413,000USD | -11,854,000USD |
| Depreciation | 468,000USD | 105,000USD | -4,086,000USD | -846,000USD | 176,000USD | 251,000USD | 509,000USD |
| Stock Based Compensation | 37,926,000USD | 20,802,000USD | 11,493,000USD | 8,887,000USD | 3,012,000USD | 331,000USD | 263,000USD |
| Other Non Cash Items | -2,875,000USD | -6,098,000USD | 2,271,000USD | 6,672,000USD | 4,001,000USD | 17,899,000USD | 277,000USD |
| Change In Working Capital | 22,992,000USD | 2,660,000USD | -5,869,000USD | 6,747,000USD | 3,511,000USD | 123,000USD | 516,000USD |
| Total Cash From Operating Activities | -241,104,000USD | -134,679,000USD | -92,181,000USD | -67,596,000USD | -23,708,000USD | -34,809,000USD | -10,289,000USD |
| Capital Expenditures | -630,000USD | -972,000USD | -63,000USD | -62,000USD | 0USD | -99,000USD | -125,000USD |
| Free Cash Flow | -241,734,000USD | -135,651,000USD | -92,244,000USD | -67,658,000USD | -23,708,000USD | -34,908,000USD | -10,414,000USD |
| Investments | 195,716,000USD | -425,029,000USD | -44,550,000USD | -70,490,000USD | -4,204,000USD | -42,000USD | -125,000USD |
| Total Cashflows From Investing Activities | 194,286,000USD | -425,029,000USD | -39,431,000USD | -70,552,000USD | -4,204,000USD | -42,000USD | -125,000USD |
| Net Borrowings | 23,338,000USD | 0USD | 24,741,000USD | 19,816,000USD | 4,921,000USD | 5,472,000USD | -188,000USD |
| Total Cash From Financing Activities | 308,897,000USD | 606,673,000USD | 133,541,000USD | 101,933,000USD | 53,882,000USD | 85,290,000USD | -137,000USD |
| Sale Purchase Of Stock | 0USD | -13,000USD | 0USD | 2,083,000USD | 48,961,000USD | — | — |
| Issuance Of Capital Stock | 300,500,000USD | 632,537,000USD | 114,999,000USD | 86,131,000USD | 51,176,000USD | 80,000,000USD | 0USD |
| Change In Cash | 262,079,000USD | 46,965,000USD | 1,929,000USD | -36,215,000USD | 25,970,000USD | 50,439,000USD | -10,551,000USD |
| Begin Period Cash Flow | 92,646,000USD | 45,681,000USD | 43,752,000USD | 79,967,000USD | 53,997,000USD | 3,558,000USD | 14,109,000USD |
| End Period Cash Flow | 354,725,000USD | 92,646,000USD | 45,681,000USD | 43,752,000USD | 79,967,000USD | 53,997,000USD | 3,558,000USD |
| Other Cashflows From Investing Activities | -800,000USD | 8,972,000USD | — | -70,490USD | -5,000,000USD | 57,000USD | — |
| Other Cashflows From Financing Activities | -21,922,000USD | -25,851,000USD | -6,200,000USD | -4,014,000USD | -2,215,000USD | 79,818,000USD | 51,000USD |
| Unclassified Financing Cash Flow | 307,481,000USD | 632,537,000USD | 115,000,000USD | 84,048,000USD | 2,215,000USD | -80,000,000USD | — |
| Unclassified Investing Cash Flow | — | -8,000,000USD | 5,182,000USD | — | 5,000,000USD | — | — |
| Change To Liabilities | — | — | — | 17,642,000USD | 5,868,000USD | 567,000USD | -291,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -36,215,000USD | 25,970,000USD | — | — |
| Unclassified Operating Cash Flow | — | — | — | — | -1,799,000USD | — | — |
| Change To Account Receivables | — | — | — | — | — | — | 159,000USD |
| Change To Inventory | — | — | — | — | — | — | -159,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.